Aquatic environments serve as repositories for pharmaceuticals, and intensive aquaculture is becoming a significant contributor to the discharge of aquaculture wastewater. The cyclical footprint of pharmaceuticals between the aquatic environment and aquaculture has emerged as a global concern. The environmental occurrence and risk assessment of pharmaceuticals in the aquatic environment via various aquaculture modes, as well as the pharmaceutical removal efficiency in different tailwater treatment systems, have been studied through yearly investigations. Thirty-four pharmaceuticals were detected in the aquaculture environment, and the dominant pharmaceuticals were enrofloxacin, sulfamethoxazole, amantadine, and florfenicol. The highest concentration of pharmaceuticals was found in the fish pond (3826 ± 29.6 ng/L) under the greenhouse aquaculture mode, especially in the early and late aquaculture stages, and the same trend was observed in the pond aquaculture mode. The tailwater removal efficiency was greater in summer months than other months, and the treatment efficiency of the recirculating treatment system was more stable. During the aquaculture period, a low risk was observed for most pharmaceuticals, except for enrofloxacin, sulfamethoxazole, ciprofloxacin and ofloxacin, which had at medium to high risk. High-risk pharmaceuticals show a high potential to contaminate the surrounding aquatic environment and adversely affect associated biota. Reassuringly, the ecological risks of the detected pharmaceuticals can be effectively reduced after tailwater treatment. This study provides valuable data for the growing system to assess risk in aquaculture and serves as a reference to establish quality standards for aquatic products.
Read full abstract